Frazier Life Sciences Management, L.P. - MERUS N V ownership

MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 94 filers reported holding MERUS N V in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
Frazier Life Sciences Management, L.P. ownership history of MERUS N V
ValueSharesWeighting
Q3 2023$17,601,975
-10.4%
746,4790.0%1.17%
-0.4%
Q2 2023$19,654,792
+43.1%
746,4790.0%1.17%
+18.1%
Q1 2023$13,735,214
+18.9%
746,4790.0%0.99%
+38.4%
Q4 2022$11,548,030
-22.8%
746,4790.0%0.72%
-37.6%
Q3 2022$14,952,000
-2.0%
746,479
+10.8%
1.15%
-20.1%
Q2 2022$15,259,000
-8.2%
673,979
+7.2%
1.44%
+1.6%
Q1 2022$16,630,000628,9791.42%
Other shareholders
MERUS N V shareholders Q1 2022
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 1,150,225$27,122,30617.94%
COMMODORE CAPITAL LP 4,428,072$104,413,93812.20%
Medicxi Ventures Management (Jersey) Ltd 1,600,000$37,728,00012.04%
Aquilo Capital Management, LLC 430,109$10,141,9709.19%
Ally Bridge Group (NY) LLC 221,384$5,220,2356.13%
Fairmount Funds Management LLC 1,881,345$44,362,1155.34%
VR Adviser, LLC 1,726,214$40,704,1264.28%
SILVERARC CAPITAL MANAGEMENT, LLC 500,000$11,790,0003.58%
DAFNA Capital Management LLC 484,870$11,433,2353.56%
Nan Fung Group Holdings Ltd 137,038$3,231,3562.62%
View complete list of MERUS N V shareholders